EMBC (Embecta Corp. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by EMBC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Milton Mayo Morris | Director | Sell | — | — |
| 2026-08-13 | Devdatt Kurdikar | President and CEO | Buy | — | — |
| 2026-08-13 | Jacob Elguicze | SVP and CFO | Buy | — | — |
| 2026-08-13 | Jeffrey Z Mann | Pres, Pharm Svc&Prod Mgmt, CLO | Buy | — | — |
| 2026-08-13 | ROBERT J. HOMBACH | Director | Buy | — | — |
| 2026-08-11 | Jean Casner | Chief Human Resources Officer | F | — | — |
| 2026-06-02 | Anthony M. Roth | VP, Chief Accounting Officer | A | — | — |
| 2026-02-13 | Christopher R Reidy | Director | A | — | — |
| 2026-02-13 | Claire Pomeroy | Director | A | — | — |
| 2026-02-13 | Milton Mayo Morris | Director | A | — | — |
| 2026-02-13 | ROBERT J. HOMBACH | Director | A | — | — |
| 2026-02-13 | Karen Prange | Director | A | — | — |
| 2026-02-13 | Carrie L Anderson | Director | A | — | — |
| 2025-12-03 | Jeffrey Z Mann | SVP, GC, Head Corp. Dev., Secy | — | — | — |
| 2025-12-03 | Jacob Elguicze | SVP and CFO | — | — | — |
| 2025-12-01 | Devdatt Kurdikar | President and CEO | MIXED | — | — |
| 2025-12-01 | Jacob Elguicze | SVP and CFO | MIXED | — | — |
| 2025-12-01 | Jeffrey Z Mann | SVP, GC, Head Corp. Dev., Secy | MIXED | — | — |
| 2025-12-01 | Anthony M. Roth | Chief Accounting Officer | MIXED | — | — |
| 2025-12-01 | Shaun Curtis | SVP, Global Manuf./Sup. Chain | MIXED | — | — |
| 2025-12-01 | Jean Casner | Chief Human Resources Officer | MIXED | — | — |
| 2025-08-11 | Jean Casner | Chief Human Resources Officer | F | — | — |
| 2025-05-23 | David F Melcher | Director | Buy | — | — |
| 2025-04-08 | Jeffrey Z Mann | SVP, GC, Head Corp. Dev., Secy | F | — | — |
| 2025-04-08 | Jacob Elguicze | SVP and CFO | F | — | — |
| 2025-04-08 | Devdatt Kurdikar | President and CEO | F | — | — |
| 2025-04-08 | Shaun Curtis | SVP, Global Manuf./Sup. Chain | F | — | — |
| 2025-02-25 | David F Melcher | Director | Buy | — | — |
| 2025-02-14 | Karen Prange | Director | A | — | — |
| 2025-02-14 | Christopher R Reidy | Director | A | — | — |
| 2025-02-14 | David Albritton | Director | A | — | — |
| 2025-02-14 | Claire Pomeroy | Director | A | — | — |
| 2025-02-14 | David F Melcher | Director | A | — | — |
| 2025-02-14 | Milton Mayo Morris | Director | MIXED | — | — |
| 2025-02-14 | ROBERT J. HOMBACH | Director | A | — | — |
| 2025-02-14 | Carrie L Anderson | Director | A | — | — |
| 2024-12-04 | Anthony M. Roth | Chief Accounting Officer | A | — | — |
| 2024-11-29 | Devdatt Kurdikar | President and CEO | MIXED | — | — |
| 2024-11-29 | Jeffrey Z Mann | SVP, GC, Head Corp. Dev., Secy | MIXED | — | — |
| 2024-11-29 | Jean Casner | Chief Human Resources Officer | MIXED | — | — |
| 2024-11-29 | Jacob Elguicze | SVP and CFO | MIXED | — | — |
| 2024-11-29 | Shaun Curtis | SVP, Global Manuf./Sup. Chain | MIXED | — | — |
| 2024-08-13 | Jean Casner | Chief Human Resources Officer | F | — | — |
| 2024-05-14 | Jacob Elguicze | SVP and CFO | F | — | — |
| 2024-04-08 | Devdatt Kurdikar | President and CEO | F | — | — |
| 2024-02-13 | Devdatt Kurdikar | President and CEO | F | — | — |
| 2024-02-12 | David F Melcher | Director | Buy | — | — |
| 2024-02-09 | Milton Mayo Morris | Director | A | — | — |
| 2024-02-09 | Karen Prange | Director | A | — | — |
| 2024-02-09 | Claire Pomeroy | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President and CEO | 804,918 | — |
| — | SVP and CFO | 309,138 | — |
| — | Pres, Pharm Svc&Prod Mgmt, CLO | 262,915 | — |
| — | Director | 109,587 | — |
| — | SVP, Global Manuf./Sup. Chain | 95,323 | — |
| — | Director | 86,681 | — |
| — | Chief Human Resources Officer | 85,914 | — |
| — | VP, Chief Accounting Officer | 78,833 | — |
| — | Director | 70,122 | — |
| — | Director | 66,127 | — |
| — | Director | 64,581 | — |
| — | Director | 64,581 | — |
| — | Director | 53,828 | — |
| — | Director | 39,743 | — |
| — | SVP and CHRO | 30,250 | — |
| — | VP, CAO & Corp. Controller | 21,054 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the EMBC quote page; the site-wide leaderboard is on the insider transactions hub.